OPTIMIZATION OF PATHOGENETIC THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE
Authors:
- 1 April 2020
- journal article
- research article
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 73 (4) , 773-776
Abstract
The aim of the study is to increase the effectiveness of the treatment of exacerbation of COPD group B GOLD II with the use of combined therapy of the combined drug PulmoBRIZ containing two components - ambroxol and acetylcysteine and the course of halotherapy. Materials and methods: We observed 60 patients with COPD B, GOLD II. They were divided into two groups: the first - the main (n=30) - patients receiving basic therapy, mucolytic therapy - a combination of Ambroxol and acetylcysteine - 200/30 to 1 tabl. 2 times a day, number 7 days and, from the 3rd day - sessions of halotherapy 1 time per day № 10. The second group, the control group (n=30), followed only basic therapy, did not take mucolytics and halotherapy sessions. Results: Patients receiving therapy with the combination of ambroxol and acetylcysteine and halotherapy sessions experienced a significant increase in FEV1 by 8.3% (p <0.05); the Tiffon index was 7.2% (p<0.05), reactive anxiety levels (RA) and manifestations of autonomic dysfunction decreased, whereas in patients in the control group these indicators did not improve significantly. Conclusions: The proposed complex therapy of COPD patients with the inclusion of the combined drug ambroxol and acetylcysteine and halotherapy sessions contributes to the improvement of the quality of life of patients.Keywords
This publication has 5 references indexed in Scilit:
- The Effectiveness of Patient-Oriented Correction of Adherence to Treatment in Patients with Arterial Hypertension and Comorbid Chronic Obstructive Pulmonary DiseaseLviv clinical bulletin, 2018
- Speleotherapy, halotherapy, haloaerosoltherapy: definitions, mechanisms of influence, perspectives of usage (part II)Asthma and allergy, 2018
- The Place Of Mucolytics In The treatment Of Inflammatory Respiratory DiseasesShidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini, 2017
- Assessment of the quality of life in patients with chronic obstructive pulmonary disease according to concomitant disorders of psycho-emotional sphereScienceRise: Medical Science, 2017
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003COPD: Journal of Chronic Obstructive Pulmonary Disease, 2004